![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | (2006.01) |
A61K 38/08 | (2013.01) | ||
A61K 38/08 | (2019.01) | ||
C07K 14/5759 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 27/02 | (2018.01) | ||
A61P 27/02 | (2006.01) | ||
A61K 9/0048 | (2013.01) | ||
C07K 14/47 | (2006.01) | ||
A61K 38/13 | (2013.01) | ||
C07K 7/06 | (2006.01) | ||
C07K 14/47 | (2013.01) | ||
A61K 38/22 | (2013.01) | ||
A61K 38/00 | (2013.01) | ||
C07K 7/06 | (2013.01) | ||
A61K 31/4725 | (2013.01) |
(11) | Number of the document | 3288577 |
(13) | Kind of document | T |
(96) | European patent application number | 16789840.2 |
Date of filing the European patent application | 2016-04-29 | |
(97) | Date of publication of the European application | 2018-03-07 |
(45) | Date of publication and mention of the grant of the patent | 2021-10-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2016/030142 |
Date | 2016-04-29 |
(87) | Number | WO 2016/179007 |
Date | 2016-11-10 |
(30) | Number | Date | Country code |
201562156127 P | 2015-05-01 | US |
(72) |
HSU, Henry , US
|
(73) |
Allysta Pharmaceuticals, Inc. ,
19 Davis Drive, Belmont, California 94002,
US
|
(54) | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS |
ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS |